Parents' pain catastrophizing in children with juvenile idiopathic arthritis
Official title: Investigation of Biopsychosocial Characteristics According to Catastrophizing of Pain Reported by Parents in Patients Diagnosed With JIA
Run by Hacettepe University · NCT07185750 · Data updated 2026-11-12
See if parents' worrying and negative thoughts about their child's pain are linked to treatment adherence and biopsychosocial outcomes in children with juvenile idiopathic arthritis.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 7 Years to 18 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Hacettepe University Academic / other |
| Locations | 1 site (Çankaya, Ankara) |
| Status | Recruiting |
| Started | August 4, 2025 |
| Main results expected | August 4, 2026 |
| Study ends | August 4, 2027 |
| Registry record updated | September 22, 2025 |
| Trial ID | NCT07185750 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 7–18 with a diagnosis of JIA whose parents agree to complete study questionnaires and who do not have advanced organ, neurological disease, malignancy, or recent major orthopedic surgery are ideal candidates.
✕Probably not a fit
Patients with severe comorbid organ or neurological disease, malignancy, recent major orthopedic surgery, or families unwilling to participate are unlikely to benefit from this observational questionnaire study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study enrolls children aged 7–18 with diagnosed juvenile idiopathic arthritis and their parents to complete questionnaires measuring parental pain catastrophizing and related biopsychosocial factors. Researchers will compare questionnaire responses to identify patterns between parent catastrophizing levels and children's treatment adherence, pain experience, and psychosocial characteristics. Key exclusions include advanced heart, lung, liver, or kidney disease, neurological disease, malignancy, and recent major orthopedic surgery. The study is conducted at Hacettepe University and uses standardized survey instruments without administering any experimental treatments.
Why it matters
Potential benefit: If successful, the findings could help target family-centered interventions to reduce parental catastrophizing and improve children's adherence and pain outcomes.
How similar studies have gone: Prior pediatric chronic pain and JIA research has linked higher parental catastrophizing to worse child pain and coping, so this approach builds on established findings rather than being entirely novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Between 7-18 years of age * Diagnosed with JIA * Individuals who volunteer to participate in the study will be included. Exclusion Criteria: * Having advanced heart/lung/liver/kidney disease, neurological disease, or malignancies * Having undergone major orthopedic surgery * Not volunteering to participate in the study
Where it's running
-
Hacettepe University
Çankaya, Ankara, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Orkun Tüfekçi, PT, PhD(c)
- Email: orkuntf@gmail.com
- Phone: 5319502648
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting the course of early-onset juvenile idiopathic arthritis using a multidimensional model
Researchers are testing a comprehensive model to predict how early-onset JIA will progress in affected children and how a small control group with iridocyclitis compares.
-
Understanding subtypes of chronic musculoskeletal pain in youth
This observational study tests whether distinct brain and immune profiles can explain chronic musculoskeletal pain in teens and young adults to guide more precise treatments.
-
Open-label extension with filgotinib for juvenile idiopathic arthritis
This long-term open-label extension sees if filgotinib stays safe and continues to control symptoms in children aged 8–17 with polyarticular or systemic juvenile idiopathic arthritis who benefited from earlier treatment.
-
Structured or video-game–based core stabilization for children with juvenile idiopathic arthritis
This study will try whether a regular structured core exercise program or a fun exergaming-based core program helps children aged 8–13 with juvenile idiopathic arthritis improve strength, reduce pain, and move better.
-
Tofacitinib in Juvenile Idiopathic Arthritis
This study looks at real-world use of tofacitinib to see if it helps control Juvenile Idiopathic Arthritis in kids over about 12 months.
-
Butantan live tetravalent dengue vaccine for people with autoimmune rheumatic diseases
This study will test whether a single dose of the Butantan live tetravalent dengue vaccine is safe and produces immune responses in clinically stable people aged 12–59 with autoimmune rheumatic diseases compared with matched healthy volunteers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.